Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BrightSpire Capital, Inc. Class A Common Stock (NY:BRSP)

5.310 -0.070 (-1.30%)
Official Closing Price Updated: 7:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BrightSpire Capital, Inc. Class A Common Stock

< Previous 1 2 3 4 Next >
BrightSpire Capital, Inc. Announces First Quarter 2023 Earnings Results and Conference Call Date
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital Announces $0.20 Per Share Dividend for First Quarter 2023
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. Announces 2023 Annual Meeting of Stockholders
From BrightSpire Capital, Inc.
Via Business Wire
The Best-Performing Mortgage REITs In 2023
Among real estate investment trusts (REITs), one of the most popular subsectors with investors are mortgage REITs (mREITs). Although mREITs can be extremely volatile, their dividend yields are usually... 
Via Benzinga
Looking Into BrightSpire Capital's Return On Capital Employed
 
Via Benzinga
Recap: BrightSpire Capital Q1 Earnings
BrightSpire Capital (NYSE:BRSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
 
Via Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday! 
Via InvestorPlace
Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
BrightSpire Capital, Inc. Prices Secondary Offering by DigitalBridge Group, Inc.
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. Announces Secondary Offering of 30,358,213 Shares of Class A Common Stock by DigitalBridge Group, Inc.
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. Announces Fourth Quarter & Full Year 2022 Financial Results
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc.; Tax Treatment of 2022 Dividends
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. Announces Fourth Quarter and Full Year 2022 Earnings Results and Conference Call Date
From BrightSpire Capital, Inc.
Via Business Wire
A Look Into Real Estate Sector Value Stocks
 
Via Benzinga
BrightSpire Capital Announces $0.20 Per Share Dividend for Fourth Quarter 2022
From BrightSpire Capital, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
 
Via Benzinga
These 3 Mortgage REITs Have Yields Of Over 13% And Are Trading For Far Less Than They're Worth
The VanEck Mortgage REIT Income ETF (ARCA: MORT) is down roughly 31% year-to-date, as a series of interest rate hikes by the Federal Reserve has sent a shock through real estate-related industries.... 
Via Benzinga
BrightSpire Capital: Q3 Earnings Insights
BrightSpire Capital (NYSE:BRSP) reported its Q3 earnings results on Wednesday, November 2, 2022 at 08:30 AM. Here's what investors need to know about the announcement. Earnings BrightSpire Capital... 
Via Benzinga
BrightSpire Capital, Inc. Announces Third Quarter 2022 Financial Results
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. Announces Third Quarter 2022 Earnings Results and Conference Call Date
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital Announces $0.20 Per Share Dividend for Third Quarter 2022
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital: Q2 Earnings Insights
  BrightSpire Capital (NYSE:BRSP) reported its Q2 earnings results on Wednesday, August 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
BrightSpire Capital, Inc. Announces Second Quarter 2022 Financial Results
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. Announces Second Quarter 2022 Earnings Results and Conference Call Date
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital Announces $0.20 Per Share Dividend for Second Quarter 2022
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. to Present at Nareit’s REITweek 2022 Investor Conference
From BrightSpire Capital, Inc.
Via Business Wire
BrightSpire Capital, Inc. Announces $100 Million Common Stock Repurchase Plan
From BrightSpire Capital, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.